300347.SZ
泰格医药
SZSE · Healthcare · M 科研服务 · CN
CNY 49.16
−9.58%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.03x
- Debt / assets
- 0.05x
- Debt / EBITDA
- 1.14x
- Net debt / EBITDA
- -0.58x
Liquidity & coverage
- Current ratio
- 2.30x
- Quick ratio
- 2.28x
- Cash ratio
- —
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- CNY 3.7B
Cash & dividend
- FCF / debt
- 0.71x
- Cash flow / debt
- 0.86x
- Dividend per share
- CNY 0.13
- Dividend yield
- 0.3%
- Dividend growth 1y
- -58.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026